C85.77 Other specified types of non-Hodgkin's lymphoma, spleen

Name of the Condition

• Other specified types of non-Hodgkin's lymphoma, spleen
• C85.77

Summary

Other specified types of non-Hodgkin's lymphoma, spleen, is a subtype of non-Hodgkin lymphoma (NHL) involving the spleen. This code applies when the lymphoma type is known but not classified into a more specific subcategory, and the site of involvement is limited to the spleen. NHL arises from abnormal lymphocyte growth in the lymphatic system, which is part of the immune system.

Causes

The exact cause of this condition is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections (e.g., Epstein-Barr virus), immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

• Advanced age (more common in older adults)
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Certain infections (e.g., hepatitis C, H. pylori)
• Exposure to chemicals (e.g., pesticides, herbicides)
• Family history of lymphoma
• Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

• Enlarged spleen (splenomegaly)
• Abdominal discomfort or fullness
• Fatigue or weakness
• Fever, night sweats, or unexplained weight loss
• Anemia or easy bruising/bleeding

Diagnosis

Diagnosis typically involves a combination of physical examination, imaging studies (e.g., CT or MRI of the abdomen), and biopsy of the spleen or affected lymph nodes. Blood tests may assess for anemia, infection, or organ function. Pathology reports confirm the presence of lymphoma and help determine the subtype, while staging evaluates the extent of disease.

Treatment Options

Treatment depends on the lymphoma subtype, stage, and patient health. Options may include chemotherapy, immunotherapy, targeted therapy, or radiation therapy. In some cases, splenectomy (surgical removal of the spleen) may be considered. Treatment plans are tailored to the individual and often involve a multidisciplinary team.

Prognosis and Follow-Up

Prognosis varies based on the lymphoma subtype, stage, and response to treatment. Regular follow-up appointments monitor for recurrence or complications. Imaging, blood tests, or biopsies may be used to assess treatment effectiveness. Long-term surveillance is important, especially for patients at risk of relapse.

Complications

Potential complications include infection (due to spleen removal or immune suppression), anemia, organ damage from tumor growth, or treatment-related side effects (e.g., fatigue, nausea). Rarely, lymphoma may spread to other organs or transform into a more aggressive form.

Lifestyle & Prevention

Maintaining a healthy lifestyle, including a balanced diet, regular exercise, and avoiding known carcinogens (e.g., tobacco), may support overall health. For patients with weakened immune systems, preventing infections (e.g., vaccinations, hygiene) is important. Follow medical advice for managing underlying conditions that increase risk.

When to Seek Professional Help

Seek medical attention if you experience persistent abdominal pain, unexplained weight loss, fever, night sweats, or signs of infection (e.g., chills, fatigue). Prompt evaluation is necessary if symptoms worsen or new symptoms develop, as early diagnosis can improve outcomes.

Tips for Medical Coders

Use C85.77 for other specified types of non-Hodgkin's lymphoma when the spleen is the documented site of involvement and the lymphoma type is not classified into a more specific subcategory. Ensure documentation supports the spleen as the primary site and confirms the lymphoma type is "other specified" rather than a more precise subtype. Verify that no other site-specific codes apply before assigning this code.